$4.53
0.14 (+3.19%)
SenoRx, Inc. (SENO)
CAPS Rating:
The Company develops, manufactures and sells minimally-invasive medical devices for the diagnosis of breast cancer.
Recs
0
I wouldn't buy it, I like p/e ratios too much - but I could see this becoming an intuitive surgical-type stock eventually. It's growing, paying off debt, & this price seems to be a reasonable jumping off point.
Recs
0
Great startup will do well. Very good business lan in a much needed area with outstanding products
Recs
0
It's already outeperformed S & P once.

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 3 of 3